533 related articles for article (PubMed ID: 23806692)
1. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid amide hydrolase determines anandamide-induced cell death in the liver.
Siegmund SV; Seki E; Osawa Y; Uchinami H; Cravatt BF; Schwabe RF
J Biol Chem; 2006 Apr; 281(15):10431-8. PubMed ID: 16418162
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells.
Siegmund SV; Wojtalla A; Schlosser M; Schildberg FA; Knolle PA; Nüsing RM; Zimmer A; Strassburg CP; Singer MV
Biochem Biophys Res Commun; 2016 Feb; 470(3):678-684. PubMed ID: 26801558
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.
Siegmund SV; Qian T; de Minicis S; Harvey-White J; Kunos G; Vinod KY; Hungund B; Schwabe RF
FASEB J; 2007 Sep; 21(11):2798-806. PubMed ID: 17440119
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.
Patsenker E; Sachse P; Chicca A; Gachet MS; Schneider V; Mattsson J; Lanz C; Worni M; de Gottardi A; Semmo M; Hampe J; Schafmayer C; Brenneisen R; Gertsch J; Stickel F; Semmo N
Int J Mol Sci; 2015 Mar; 16(4):7057-76. PubMed ID: 25826533
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB
Leonard MZ; Alapafuja SO; Ji L; Shukla VG; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
J Pharmacol Exp Ther; 2017 Dec; 363(3):314-323. PubMed ID: 28947487
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
Lau BK; Drew GM; Mitchell VA; Vaughan CW
Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase.
Vila A; Rosengarth A; Piomelli D; Cravatt B; Marnett LJ
Biochemistry; 2007 Aug; 46(33):9578-85. PubMed ID: 17649977
[TBL] [Abstract][Full Text] [Related]
14. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
16. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells.
Muccioli GG; Xu C; Odah E; Cudaback E; Cisneros JA; Lambert DM; López Rodríguez ML; Bajjalieh S; Stella N
J Neurosci; 2007 Mar; 27(11):2883-9. PubMed ID: 17360910
[TBL] [Abstract][Full Text] [Related]
19. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.
Desroches J; Guindon J; Lambert C; Beaulieu P
Br J Pharmacol; 2008 Nov; 155(6):913-24. PubMed ID: 18695638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
